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Introduction
Prostate cancer is the most frequently diagnosed cancer and the second leading cause of cancer death in males worldwide (Siegel et al., 2013) . In fact, it represents a considerable health problem for men accounting for 27,000 deaths in 2009 in the United States alone (Freedland, 2011) . Death rates from prostate cancer continue to decline reflecting improvements in early diagnosis and therapy (Siegel et al., 2013) . Potentially curative options for patients with localized disease include radical prostatectomy, radiation, and cryotherapy (Freedland, 2011) . About 35 % of patients will experience disease recurrence within 10 years of primary therapy. Treatment of recurrent, late-stage, castration-resistant, and metastatic prostate cancer remains an unsolved therapeutic challenge. The small positive impact of docetaxel chemotherapy on survival (median survival gain of less than three months) (Freedland, 2011) have necessitated the need for novel treatment strategies of advanced prostate cancer.
The evolutionarily conserved checkpoint protein kinase, mammalian target of rapamycin (mTOR), has emerged as a major effector of cell growth and proliferation via the regulation of protein and lipid synthesis (Zoncu et al., 2011) . The activity of mTOR, a key regulator of protein synthesis, is exacerbated in diseases, which are characterized by deregulated growth, such as cancer or type 2 diabetes (Zoncu et al., 2011) . mTOR is positively regulated by Akt and both kinases are frequently constitutively activated in many high grade human malignancies including advanced prostate cancer, where their activity is correlated with poor prognosis (Brown et al., 2008; Graff et al., 2009; Antonarakis et al., 2010; Zoncu et al., 2011) .
Akt and mTOR pathways are tightly interconnected by a number of positive and negative feed loops and are often considered as a single Akt/mTOR pathway (Efeyan and Sabatini, 2010; Porta et al., 2014) . Thus, in clinical trials, the mTOR inhibitor rapamycin and its analogues showed limited efficacy as anticancer drugs due to activation of prosurvival and proliferative This article has not been copyedited and formatted. The final version may differ from this version. JPET Fast Forward. Published on October 14, 2014 as DOI: 10.1124 at ASPET Journals on July 12, 2017 jpet.aspetjournals.org Downloaded from J  P  E  T  #  2  1  7  3  2  3 6 signals through Akt, as well as ERK, and other cascades (Efeyan and Sabatini, 2010; Zoncu et al., 2011) . New inhibitors of the Akt/mTOR pathway with different mechanisms of action are believed to overcome the shortcomings of conventional inhibitors (Zoncu et al., 2011) .
Between 1981 and 2002, about two thirds of the drugs approved for cancer treatment were natural products (Aggarwal et al., 2004) . The Boswellia species (Burseraceae), trees native to Ethiopia, Somalia, India, and the Arabic peninsula, produce an oleo gum resin known as olibanum or frankincense. This oleo gum resin has been traditionally used for the treatment of rheumatoid arthritis and other inflammatory diseases in many countries (Ammon, 2006) . In clinical pilot studies, beneficial effects of frankincense extracts have been reported in a variety of inflammatory diseases such as allergic asthma, inflammatory bowel diseases, arthritis, or peritumoral brain edema (Ammon, 2006; Abdel-Tawab et al., 2011) . Some reports suggest that bioactive triterpenoids may represent the pharmacologically active principle of frankincense (Syrovets et al., 2000; Syrovets et al., 2005a; Poeckel and Werz, 2006; CuazPerolin et al., 2008; Lu et al., 2008; Wang et al., 2009; Abdel-Tawab et al., 2011) .
Furthermore, many studies show antineoplastic activities of those triterpenoids, especially boswellic acids and their derivatives on different types of cancer (Syrovets et al., 2000; Syrovets et al., 2005b; Akihisa et al., 2006; Büchele et al., 2006; Lu et al., 2008; Bhushan et al., 2009; Park et al., 2011; Yadav et al., 2012; Morad et al., 2013) .
Among the pharmacologically active triterpenoids present in the oleo gum resin of Boswellia species are terpenoids with tirucallane skeletons. Thus, α ATA(7,24) and OTA have been shown to inhibit the 12-O-tetradecanoyl phorbol-13-acetate-induced inflammation in mice . We have previously demonstrated that tirucallic acids including OTA and α ATA(7,24) induce prostate cancer cell death via apoptosis and that they decreased the growth of pre-established prostate tumors in nude mice without overt systemic toxicity (Estrada et al., 2010) . It has also been reported that tirucallic acids might inhibit cell-free 5-This article has not been copyedited and formatted. The final version may differ from this version. 
Materials and Methods
Materials and Antibodies. The tirucallic acid isomers, 3α-acetyloxy-tir-8,24-dien-21-oic acid (αATA(8,24)) and 3α-acetyloxy-tir-7,24-dien-21-oic acid (αATA(7,24)), and 3oxo-tir- (Nicoletti et al., 1991) . Caspase 3 activity was analyzed using fluorometric detection of the cleaved caspase 3 substrate Z-DEVD-R110 using flow cytometry. For the detection of apoptotic cells in prostate cancer xenografts, DNA strand breaks were visualized by the terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) method (Syrovets et al., 2005b 3249 CCD camera using Visupac 22.1 software (Carl Zeiss), and quantified using ImageJ (NIH).
Determination of ROS Production. Cellular production of reactive oxygen species (ROS) was determined by the cell-permeant dye 2',7'-dichlorodihydrofluorescein diacetate (H 2 DCFDA). Upon cleavage of the acetate groups by intracellular esterases and by oxidation, the non-fluorescent H 2 DCFDA is converted to the highly fluorescent 2',7'-dichlorofluorescein (Loos et al., 2014) . PC-3 cells were treated with either α ATA(8,24) (10 μ M), OTA (10 µM), docetaxel (100 nM), or rapamycin (10 nM) for 24 h. Alternatively, cells were treated with for 24 and 48 h, were stained with 2.5 µg/ml acridine orange for 15 min at 37 ºC and analyzed by flow cytometry.
Cell Cycle Analysis. Following a 24 h treatment, PC-3 cells were stained by propidium iodide and analyzed by flow cytometry (Nicoletti et al., 1991) using FlowJo software (TreeStar Inc., Ashland, OR).
Western Immunoblotting. PC-3 cells were starved in serum-free medium overnight, pretreated with the compounds for 30 min and stimulated with 1 % FCS for a total of 6 or 8 h.
Collected cells were lysed in cold RIPA buffer in the presence of protease and phosphatase inhibitors. Cell debris was removed by high-speed centrifugation and protein concentration of the samples was determined by BCA assay. Equal amounts of protein (60 µg) were separated by SDS-PAGE, and electrophoretically transferred onto PVDF membranes. Proteins were visualized with specific antibodies and detected using corresponding HRP-coupled secondary antibodies as described (Syrovets et al., 2001 ).
Kinase Assay. The kinase assays were performed as described (Syrovets et al., 2005a; Syrovets et al., 2005b; Estrada et al., 2010; Morad et al., 2013) . Active human recombinant
His-Akt1 (100 nM) fusion protein (Biaffin GmbH, Kassel, Germany) was treated either with 3-30 µM of either tirucallic acid, Akt inhibitor VIII (Akti-1/2, 10 µM, Calbiochem), or the solvent DMSO for 15 min at 30°C before addition of the substrate and [γ- treat advanced prostate cancer (Freedland, 2011) , partially reduced the viability of the prostate cancer cells. However, about one third of the cells exhibited resistance to docetaxel, even when rather high concentrations were applied (Fig. 1C) . Similarly, the mTOR inhibitor rapamycin exhibited cytostatic activity on PC-3 cells with about 50% remaining viable irrespective of the applied rapamycin concentration (Fig. 1C) . The cytotoxic effect of α ATA(8,24) on the cancer cells appeared to be specific, because the tirucallic acid were not toxic for peripheral blood mononuclear cells (Fig. 1D) . Similarly, α ATA(8,24) and OTA inhibited the proliferation of PC-3 xenografts on chorioallantoic membranes of fertilized chicken eggs as assessed by the expression of the proliferation antigen Ki-67 (Fig. 1E) ; α ATA(8,24) (3 µM) was as active as docetaxel (100 nM) and more active than rapamycin (10 nM).
α ATA(8,24) Triggers Apoptosis in Prostate Cancer Cells in Vitro and in Vivo. Caspase 3 is an effector caspase, that when activated cleaves many important cellular substrates, which causes membrane blebbing, disassembly of the cell structure, and DNA fragmentation leading finally and inevitably to cell death. Caspase 3 is activated in apoptotic cells both, by extrinsic (death ligand) and intrinsic (mitochondrial) pathways (Lawen, 2003) . About 17% of the cells treated with α ATA(8,24) for 24 h exhibited active caspase 3 (Fig. 2A) ; after 48 h, the number of cells with active caspase-3 increased up to 50%. Activation of caspase 3 was observed in
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Analysis of the cell membrane asymmetry revealed that treatment of PC-3 cells with α ATA(8,24) for 48 h resulted in a significant increase of the percentage of annexin V-positive cells, whereas, the increase caused by OTA was much lower and not statistically significant compared to control (Fig. 2B) . α ATA(8,24) was as active as docetaxel in inducing the phosphatidylserine expression on the cells surface, whereas rapamycin had no effect on this parameter indicating no induction of apoptosis in PC-3 cells (Fig. 2B ). These data are consistent with the observation that rapamycin did not induce caspase 3 activation and DNA fragmentation in prostate cancer cells ( Fig. 2A and 2C ). In contrast, the majority of cells treated with α ATA(8,24) for 72 h were subdiploidal and in the group treated with OTA, about 30 % of the cells were apoptotic. In agreement with the data demonstrating that about the half of PC-3 cells remain viable after treatment with docetaxel ( Fig. 1. B) , DNA fragmentation was observed only in about 40% of the prostate cancer cells treated with docetaxel ( Fig. 2 . C).
The in vitro data were further validated by experiments performed in an in vivo xenotransplantation model using fertilized chicken eggs. Thus, α ATA(8,24) potently induced DNA strand breaks, which indicates induction of apoptosis in the prostate cancer xenografts (Fig. 2D ). The amount of apoptotic cells was also increased in xenografts treated with OTA and docetaxel, although to a lesser extent compared to α ATA(8,24 of the mitochondrial permeability transition pore, release of cytochrome c and other proapoptotic molecules, formation of the apoptosome, and caspase 3 activation (Lawen, 2003) . The mitochondrial integrity was analyzed using JC-1 dye, which accumulates within mitochondria in a potential-dependent manner characterized by a fluorescence emission shift from green to red. Consequently, mitochondrial depolarization is characterized by a decrease in the red/green fluorescence intensity ratio. Treatment of cells with α ATA(8,24) for 24 h led to an increase in the red/green fluorescence intensity ratio indicating hyperpolarization, which was followed by a dramatic loss of the mitochondrial membrane potential after 48 h (Fig. 3A) .
Similarly, a loss of the mitochondrial membrane potential was observed in cells treated with docetaxel, whereas OTA and rapamycin induced mitochondrial membrane hyperpolarization but no loss of the membrane potential (Fig. 3A) . These data are consistent with those demonstrating that OTA is a weak inducer of apoptosis and rapamycin is cytostatic rather than proapoptotic (Fig. 1B,D and Fig. 2 ).
Most cancer cells exhibit increased aerobic glycolysis and oxidative stress, compared with their normal counterparts (Trachootham et al., 2009 ). An increase in the production of free oxygen radicals (ROS) above a certain level may enhance the susceptibility of cancer cells to a chemotherapeutic drug. Dissipation of the mitochondrial membrane potential in PC-3 cells treated with α ATA(8,24) might amplify ROS formation and increased oxidative stress.
Indeed, following 24 h treatment of PC-3 cells with α ATA(8,24), the cells exhibited an increased production of ROS and superoxide, as analyzed by H 2 DCFDA and MitoSOX fluorescent dyes, respectively (Fig. 3B,C) . OTA and docetaxel also induced oxidative stress in prostate cancer cells, although to a lesser extent compared to α ATA (8, 24) . No significant oxidative stress was detected in cells treated with rapamycin (Fig. 3B,C) . other acidic vesicular organelles in the execution of apoptosis (Aits and Jaattela, 2013) . Thus, lysosomes contain cysteine cathepsins, which, when released through limited permeabilization of the lysosomal membrane might promote apoptotic cell death. On the other hand, mitochondrial ROS could destabilize the lysosomal membrane by lipid peroxidation and damage of membrane proteins (Aits and Jaattela, 2013) . Staining with the acidophilic dye acridine orange, which is protonated and emits orange light at low pH, allows analysis of the activity of the proton pump of acidic vesicular organelles (Moriyama et al., 1982) . (8, 24) , OTA, as well as docetaxel and to a lesser extent rapamycin induced activation of the proton pump in PC-3 cells, as manifested by a fluorescence shift to the right. The activation was evident already after 24 h of treatment, and was more pronounced after 48 h (Fig. 4) . Similarly, within this time, the number of cells with decreased fluorescence exhibiting lysosomal rupture was increased (shown by a fluorescence shift to the left).
Docetaxel was the strongest inducer of lysosomal membrane permeability, followed by α ATA(8,24) and OTA (Fig. 4) . No fluorescence decrease and, thus, no damage of the lysosomal membrane was observed in cells treated with rapamycin. formation (Fig. 5A ). Similar effects were observed after addition of the mTOR inhibitor, rapamycin, but not after treatment with the antimitotic drug docetaxel.
S6K1 is a downstream target of mTORC1, a mTOR complex, which preferentially drives the translation of mRNAs for pro-tumorigenic genes, including cell cycle regulators, promoting tumorigenesis (Zoncu et al., 2011) . mTORC1 is, in turn, regulated by Tuberous Sclerosis Complex 2 (TSC2), an Akt substrate (Fig. 5D) . We have previously shown that tirucallic acids inhibit the Akt kinase activity (Estrada et al., 2010) . Indeed, α ATA(8,24) is a potent Akt inhibitor, which inhibited Akt1 activity in kinase assay more efficiently than known tirucallic acids (Fig. 5B ).
As expected, treatment of PC-3 cells with α ATA(8,24) for 8 h resulted in decreased protein levels of cyclin D 1 and its corresponding partner CDK4, cyclin E and its corresponding partner CDK2, as well as cyclin B 1 . The expression of the phosphorylated form of retinoblastoma protein was also significantly reduced by treatment with α ATA(8,24) and rapamycin, and to a lesser extent, by OTA. Interestingly, the antimitotic agent docetaxel inhibited slightly the expression of only cyclin E and CDK4, and significantly increased the expression of the cyclin B1 (Fig. 5C ) due to inhibition of the cyclin B1 proteolysis by the proteasome (Clute and Pines, 1999). Not unexpected, inhibition of the cell-cycle regulators by α ATA(8,24) and OTA resulted in dysregulation of the cell cycle of the prostate cancer cells within 24 h. Docetaxel induced a strong accumulation of PC-3 cells in the G 2 phase of the cell cycle, which might be a result of its binding and stabilization of microtubules, followed by mitotic catastrophe (Yvon et al., 1999) . By contrast, rapamycin did not affect the cell distribution throughout the cell cycle within 24 h after treatment (Fig. 5E ).
Discussion
This article has not been copyedited and formatted. The final version may differ from this version. The present study provides evidence that the tirucallic acid isomer α ATA (8,24) of electron transport and energy metabolism, and loss of mitochondrial transmembrane potential are the events responsible for the critical role of mitochondria in apoptotic cell death (Green and Reed, 1998; Fischer and Schulze-Osthoff, 2005 consequence of the mitochondrial membrane dysfunction that manifests itself in a collapse of transmembrane potential, uncoupling of respiration from oxidative phosphorylation, high ROS production, followed by activation of caspase 3 and cell death. Here, we provide evidence that tirucallic acids induce changes in mitochondrial membrane leading to an early hyperpolarization, followed by depolarization and collapse of the mitochondrial membrane potential. The hyperpolarization can be a sign of increased number of mitochondria per cell or an increase in matrix volume. In turn, mitochondrial swelling could lead to the rupture of its outer membrane, followed by dissipation of the mitochondrial membrane potential, cytochrome c release, and caspase 3 activation (Green and Reed, 1998; Fischer and SchulzeOsthoff, 2005) , events, which take place in cells treated with α ATA(8,24).
These processes were accompanied by an increase of ROS and superoxide in the cytosol, which can likewise act as mediators of apoptotic pathways in particular through hydrogen peroxide, which reacts in lysosomes with ferruginous material delivered there by autophagy.
Highly reactive ROS produced in lysosomes as a result of Fenton-type reactions can damage the lysosomal membrane and induce release of lysosomal cargo into the cytosol thereby promoting apoptosis (Repnik et al., 2013) . Overall, this leads to a point of no return during the commitment stage of apoptosis and suggests that apoptosis induced by tirucallic acids proceeds mainly through the mitochondrial pathway. Due to the different redox states of normal and malignant cells and the higher susceptibility of cancer cells towards ROSmediated apoptosis (Trachootham et al., 2009) increased lysosome number. Such increased staining of acidic vesicular organelles is also consistent with the induction of acidic autolysosomes, a late event in autophagy induction (Klionsky et al., 2012) . The lysosomal membranes contain highly specialized glycosylated proteins, which form a tight barrier between the luminal milieu with an acidic pH of <5 and about 50 highly destructive hydrolases. During lysosomal membrane permeabilization, commonly named LMP, detrimental lysosomal proteins may leak into the cytosol and damage membranes of other organelles. Thus, the mitochondrial membrane permeabilization could be a result of the increased permeabilization of the lysosomal membrane. ROS may, in turn, contribute to lysosomal membrane permeabilization by causing lipid peroxidation and lysosomal membrane damage proteins as has been discussed above (Aits and Jaattela, 2013) . ( Zoncu et al., 2011; Morad et al., 2013) . Rapamycin, which promotes autophagy, even protects cells against a range of proapoptotic insults. It is believed that autophagy, which enhances clearance of mitochondria, reduces cytosolic cytochrome c release and downstream caspase activation thereby acting prosurvival (Repnik et al., 2013) . All forms of autophagy, in turn, rely on lysosomes for the subsequent degradation of their cargo. Under conditions of oxidative stress, excess ROS diffusing into lysosomes and autolysosomes fully loaded with autophagic cargo can easily destabilize membranes and cause lysosomal membrane permeabilization (Aits and Jaattela, 2013) . Furthermore, lysosomal membrane dysfunction not only leads to the release of lysosomal proteases into the cytosol but also reduces the degradation rate of the endocytotic system impairing the cytoprotective role of autophagy and lowering the apoptotic threshold (Repnik et al., 2013) . Indeed, in cells treated with α ATA(8,24), the increased ROS and superoxide production might be amplified by the positive feedback loop between mitochondria and acidic vesicular organelles, whereas in cells treated with rapamycin, the ROS production and the feedback loop were absent. with α ATA(7,24) (violet carbon sticks) (oxygen -red, hydrogen atoms are omitted for clarity.
Superimpositions of three dimensional structures were performed using the "Discovery Studio (8, 24) or OTA (both 3 µM), docetaxel (100 nM) or rapamycin (10 nM) for 3 consecutive days. Xenografts were analyzed using TUNEL as apoptosis marker (brown stain). All data are mean ± SEM, *P < 0.05, **P < 0.01, ***P < 0.001 vs control. 
